GRIN2A c.2400C>A ;(p.C800*)

Variant ID: 16-9862903-G-T

NM_001134407.1(GRIN2A):c.2400C>A;(p.C800*)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Genomic Analysis of Tumors from Patients with Glioblastoma with Long-Term Response to Afatinib.

Oncotargets And Therapy
Owen, Scott S; Alken, Scheryll S; Alshami, Jad J; Guiot, Marie-Christine MC; Kavan, Petr P; Reardon, David A DA; Muanza, Thierry T; Gibson, Neil N; Pemberton, Karine K; Solca, Flavio F; Cseh, Agnieszka A; Saran, Frank F
Publication Date: 2022

Variant appearance in text: GRIN2A: 2400C>A
PubMed Link: 35422631
Variant Present in the following documents:
  • Main text
  • ott-15-367.pdf
View BVdb publication page



Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.

Oncotarget
Alshami, Jad J; Guiot, Marie-Christine MC; Owen, Scott S; Kavan, Petr P; Gibson, Neil N; Solca, Flavio F; Cseh, Agnieszka A; Reardon, David A DA; Muanza, Thierry T
Publication Date: 2015-10-20

Variant appearance in text: GRIN2A: 2400C>A
PubMed Link: 26423602
Variant Present in the following documents:
  • Main text
  • oncotarget-06-34030.pdf
View BVdb publication page